The US pharmaceutical company Pfizer is working on an anti-viral drug to treat the disease after vaccinating against corona. This oral medication can play an important role in preventing corona.

The drug may arrive later this year.

Pfizer’s chief executive officer (CEO) Albert Borla made the remarks in an interview with CNBC.

About the drug, Albert Borla said that if the clinical trial goes well and the Food and Drug Administration (FDA) approves, the drug could be delivered across the United States by the end of the year.

The CEO of Pfizer is hopeful that the drug will be more effective in preventing various types of corona.

Experts say the drug could be a game changer in preventing the corona virus. This drug will prevent early patients from going to the hospital after being infected.

Researchers hope that this drug will not allow the corona to expand. In addition, it will prevent the patient from going to the hospital immediately after the infection.

Pfizer is reportedly trying to develop a vaccine for people aged 6 months to 11 years. On the other hand, their vaccines made for 12 to 15 year olds have been found to be 100% effective. Pfizer is optimistic about getting it approved.

US company Pfizer and German company Bioentech have jointly developed a vaccine for coronavirus. Its application is going on in different countries of the world. Pfizer claims that the corona vaccine they invented is 95 percent effective.

MN / 29 April